Inhibition of miR301 enhances Akt-mediated cell proliferation by accumulation of PTEN in nucleus and its effects on cell-cycle regulatory proteins

Mayur V. Jain; Ahmad Shareef; Wirginia Likus; Artur Cieślar-Pobuda; Saeid Ghavami; Marek J. Łos

doi:10.18632/oncotarget.7996

Oncotarget

Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science.

Its scope is unique. The term "oncotarget" encompasses all molecules, pathways, cellular functions, cell types, and even tissues that can be viewed as targets relevant to cancer as well as other diseases. The term was introduced in the inaugural Editorial, Introducing Oncotarget.

As of January 1, 2022, Oncotarget has shifted to a continuous publishing model. Papers will now be published continuously within yearly volumes in their final and complete form and then quickly released to Pubmed.

Subscribe to receive alerts once a paper has been published by Oncotarget.

Impact Journals, LLC is the publisher of Oncotarget: www.impactjournals.com.

Impact Journals is a member of the Wellcome Trust List of Compliant Publishers.

Impact Journals is a member of the Society for Scholarly Publishing.

On December 23, 2022, Oncotarget server experienced a DDoS attack. As a result, Oncotarget site was inaccessible for a few hours. Oncotarget team swiftly dealt with the situation and took it under control. This malicious action will be reported to the FBI.

Research Papers:

Inhibition of miR301 enhances Akt-mediated cell proliferation by accumulation of PTEN in nucleus and its effects on cell-cycle regulatory proteins

Mayur V. Jain, Ahmad Shareef, Wirginia Likus, Artur Cieślar-Pobuda, Saeid Ghavami and Marek J. Łos _

PDF | HTML | Supplementary Files | How to cite

Oncotarget. 2016; 7:20953-20965. https://doi.org/10.18632/oncotarget.7996

Metrics: PDF 1498 views | HTML 1922 views | ?

Abstract

Mayur V. Jain1, Ahmad Shareef1, Wirginia Likus2, Artur Cieślar-Pobuda3, Saeid Ghavami4, Marek J. Łos5,6

1Department of Clinical & Experimental Medicine, Division of Cell Biology Integrative Regenerative Medicine Center (IGEN), Linköping University, Linköping, Sweden

2Department of Human Anatomy, School of Medicine in Katowice, Medical University of Silesia, Katowice, Poland

3Institute of Automatic Control, Silesian University of Technology, Gliwice, Poland

4Department of Human Anatomy and Cell Science, College of Medicine, Faculty of Health Sciences, University of Manitoba, Winnipeg, Canada

5Department of Pathology, Pomeranian Medical University, Szczecin, Poland

6LinkoCare Life Sciences AB, Linköping, Sweden

Correspondence to:

Marek J. Łos, e-mail: [email protected]

Keywords: miR301, PTEN, PI3K, AKT, mTOR

Received: December 31, 2015 Accepted: February 18, 2016 Published: March 8, 2016

ABSTRACT

Micro-RNAs (miRs) represent an innovative class of genes that act as regulators of gene expression. Recently, the aberrant expression of several miRs has been associated with different types of cancers. In this study, we show that miR301 inhibition influences PI3K-Akt pathway activity. Akt overexpression in MCF7 and MDAMB468 cells caused downregulation of miR301 expression. This effect was confirmed by co-transfection of miR301-modulators in the presence of Akt. Cells overexpressing miR301-inhibitor and Akt, exhibited increased migration and proliferation. Experimental results also confirmed PI3K, PTEN and FoxF2 as regulatory targets for miR301. Furthermore, Akt expression in conjunction with miR301-inhibitor increased nuclear accumulation of PTEN, thus preventing it from downregulating the PI3K-signalling. In summary, our data emphasize the importance of miR301 inhibition on PI3K-Akt pathway-mediated cellular functions. Hence, it opens new avenues for the development of new anti-cancer agents preferentially targeting PI3K-Akt pathway.

All site content, except where otherwise noted, is licensed under a Creative Commons Attribution 4.0 License.
PII: 7996

Publication Alerts

Research Papers:

Inhibition of miR301 enhances Akt-mediated cell proliferation by accumulation of PTEN in nucleus and its effects on cell-cycle regulatory proteins

Abstract